Arquivos de Asma, Alergia e Imunologia
https://www.aaai-asbai.org.br/article/doi/10.5935/2526-5393.20200066
Arquivos de Asma, Alergia e Imunologia
Original Article

Prevalência e fatores associados a sintomas de eczema atópico em adolescentes e adultos residentes na Região Sul do Brasil – Resultados do Global Asthma Network (GAN)

Prevalence and factors associated with symptoms of atopic eczema in adolescents and adults living in southern Brazil - Global Asthma Network (GAN) results

Marilyn Urrutia-Pereira; Lucas Pitrez Mocellin; Herberto Chong-Neto; Laura Simon; Pietro Rinelli; Dirceu Solé

Downloads: 0
Views: 40

Resumo

Objetivo: Embora o objetivo da Rede Global de Asma (GAN) seja entender o estado atual do eczema atópico (EA), sua prevenção e melhoria geral em seu manejo, particularmente em países de baixa e média renda, ela permite a avaliação de outras doenças alérgicas, como a asma (A) e a rinite alérgica (RA). Nosso objetivo foi determinar a prevalência de EA e fatores associados em adolescentes e seus pais/responsáveis. Método: Adolescentes (13-14 anos; n = 1.058) e seus pais/responsáveis (média = 42,1 anos; n = 896) residentes na cidade de Uruguaiana, RS, sul do Brasil, responderam aos questionários padrão do GAN. Resultados: A prevalência de EA em adolescentes foi de 8%, e a de formas graves foi de 1,3%, com predomínio no sexo feminino (67,8%). Nos adultos, a prevalência de EA foi de 3,1%. Alguns fatores de risco associados ao EA em adolescentes incluem o consumo de azeite ou de margarina. Em adultos, a exposição à umidade e manchas no passado e atual, uso de cigarros eletrônicos/narguilé, e consumo de outros laticínios foram associados a risco, e o consumo de arroz a proteção. Conclusões: A prevalência de EA em adolescentes é alta e predomina em mulheres, assim como o diagnóstico médico de EA em adultos residentes em Uruguaiana. Fatores ambientais, especialmente hábitos alimentares e umidade no domicílio, foram associados aos achados em ambos os grupos.

Palavras-chave

Eczema atópico, dermatite atópica, fatores de risco, prevalência, adolescentes, adultos, Global Asthma Network.

Abstract

Objective: Although the purpose of the Global Asthma Network (GAN) is to understand the current status of atopic eczema (AE), including prevention and general improvement in its management, particularly in low- and middle-income countries, it allows the assessment of other allergic diseases such as asthma and allergic rhinitis. Our objective was to determine the prevalence of AE and associated factors in adolescents and their parents/guardians. Method: Adolescents (13-14 years old; n = 1058) and their parents/guardians (mean = 42.1 years old; n = 896) living in the city of Uruguaiana, RS, southern Brazil, completed the standard GAN questionnaires. Results: The prevalence of AE in adolescents was 8%, and that of severe forms was 1.3%, with predominance in females (67.8%). In adults, the prevalence of AE was 3.1%. Some risk factors associated with AE in adolescents include the consumption of oil or margarine. In adults, exposure to moisture and stains in the past and currently, use of electronic cigarettes/ hookahs, and consumption of other dairy products were identified as risk factors, while rice consumption was considered a protective factor. Conclusions: The prevalence of AE in adolescents is high and the disease predominates in women, as well as the medical diagnosis of AE in adults living in Uruguaiana. Environmental factors, especially eating habits and moisture at home, were associated with the findings in both groups.

Keywords

Atopic eczema, atopic dermatitis, risk factors, prevalence, adolescents, adults, Global Asthma Network.

References

1. Ellwood P, Asher MI, Ellwood E and the Global Asthma Network Steering Group. Manual for Global Surveillance: Prevalence, Severity and Risk Factors. Auckland, New Zealand: Global Asthma Network Data Centre; 2015.

2. Ellwood P, Asher MI, Beasley R, Clayton TO, Stewart AW, ISAAC Steering Committee. The international study of asthma and allergies in childhood (ISAAC): Phase Three rationale and methods. Int J Tuberc Lung Dis. 2005;9(1):10-6.

3. Asher MI, Montefort S, Björkstén B, Lai CK, Strachan DP, Weiland SK, et al. Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys. Lancet. 2006;368(9537):733-43.

4. Dierick BJH, van der Molen T, Flokstra-de Blok BMJ, Muraro A, Postma MJ, Kocks JWH, et al. Burden and socioeconomics of asthma, allergic rhinitis, atopic dermatitis and food allergy. Exp Rev Pharmac Outc Res. 2020;20(5):437-53.

5. Morales E, Strachan D, Asher I, Ellwood P, Pearce N, GarciaMarcos L, et al. Combined impact of healthy lifestyle factors on risk of asthma, rhinoconjunctivitis and eczema in school children: ISAAC phase III. Thorax. 2019;74(6):531-8.

6. Odhiambo JA, Williams HC, Clayton TO, Robertson CF, Asher MI, and the ISAAC Phase Three Study Group. Global variations in prevalence of eczema symptoms in children from ISAAC Phase Three. J Allergy Clin Immunol. 2009;124:1251-8.

7. Global Asthma Network. Instruments for 13-14 year olds. Instructions for preparing the questionnaire [Internet]. Disponível em: in: http://www.globalasthmanetwork.org/surveillance/manual/study13.php Acessado em: dez/2017.

8. Global Asthma Network. Instruments for adults. Instructions for preparing the questionnaire [Internet]. Disponível em: http://www.globalasthmanetwork.org/surveillance/manual/studyadult.php Acessado em: dez/2017.

9. Silverberg JI, Gelfand JM, Margolis DJ, Boguniewicz M, Fonacier L, Grayson MH, et al. Patient burden and quality of life in atopic dermatitis in US adults: A population-based cross-sectional study. Ann Allergy Asthma Immunol. 2018;121(3):340-7.

10. Silverberg JI, Gelfand JM, Margolis DJ, Boguniewicz M, Fonacier L, Grayson MH, et al. Atopic Dermatitis in US Adults: From Population to Health Care Utilization. J Allergy Clin Immunol Pract. 2019;7(5):1524-1532.e2.

11. Chung J, Simpson EL. The socioeconomics of atopic dermatitis Ann Allergy Asthma Immunol. 2019;122(4):360-6.

12. Solé D, Mallozi MC, Sano F. Dermatite atópica em adultos: além da pele. Arq Asma Alerg Imunol. 2020;4(1):103-20.

13. Pedersen CJ, Uddin MJ, Saha SK, Darmstadt GL. Prevalence of atopic dermatitis, asthma and rhinitis from infancy through adulthood in rural Bangladesh: a population-based, cross-sectional survey. BMJ Open. 2020;10(11):e042380.

14. Arnedo-Pena A, Puig-Barberà J, Artero-Civera A, Romeu-Garcia MA, N Meseguer-Ferrer N, Fenollosa-Amposta C, et al. Atopic dermatitis incidence and risk factors in young adults in Castellon (Spain): A prospective cohort study. Allergol Immunopathol (Madr). 2020;48(6):694-700.

15. Deckers IA, McLean S, Linssen S, Mommers M, van Schayck CP, Sheikh A, et al. Investigating international time trends in the incidence and prevalence of atopic eczema 1990-2010: a systematic review of epidemiological studies. PLoS One. 2012; 7: e39803.

16. Kantor R, Silberberg JI. Environmental risk factors and their role in the management of atopic dermatitis. Exp Rev Clin Immunol. 2017;13(1):15-26.

17. Ellwood P, Williams H, Ait-Khaled N, Bjorksten B, Robertson C, Group IPIS. Translation of questions: the International Study of Asthma and Allergies in Childhood (ISAAC) experience. Int J Tuberc Lung Dis. 2009;13:1174-82.

18. Global Asthma Network - centers registered. [Internet]. Disponível em:http://www.globalasthmanetwork.org/about/centres.php?region=all Acessado em: 30/01/2020.

19. Wei J, Gerlich J, Genuneit J, Nowak D, Vodelberg C, von Mutius E, et al. Hormonal factors and incident asthma and allergic rhinitis during puberty in girls. Ann Allergy Asthma Immunol. 2015;115(1):21‑27e2.

20. Pols DHJ, Wartna JB, van Alphen EI, Moed H, Rasenberg N, Bindels PJE, et al. Interrelationships between Atopic Disorders in Children: A Meta-Analysis Based on ISAAC Questionnaires. PLoS One. 2015;10(7):e0131869.

21. Solé D, Rosário-Filho NA, Sarinho ES, Camelo-Nunes IC, Paes Barreto B, Medeiros ML, et al. Prevalence of asthma and allergic diseases in adolescents: nine-year follow-up study (2003-2012). J Pediatr (Rio J). 2015;9:30-5.

22. Barbarot S, Auziere S, Gadkari A, Girolomoni G, Puig L, Simpson EL, et al. Epidemiology of atopic dermatitis in adults: Results from an international survey. Allergy. 2018;73(6):1284-93.

23. Wang J, Zhao Z, Zhang Y, Li B, Huang X, Zhang X, et al. Asthma, allergic rhinitis and eczema among parents of preschool children in relation to climate, and dampness and mold in dwellings in China. Environment Int. 2019;130:104910.

24. Singh S, Sharma BB, Salvi S, Chhatwal J, Jain KC, Kumar L, et al. Allergic rhinitis, rhinoconjunctivitis, and eczema: prevalence and associates factors in children. Clin Respir J. 2018;12(2):547-56.

25. Sharpe RA, Thornton CR, Tyrrell J, Nikolaou V, Osborne NJ. Variable risk of atopic disease due to indoor fungal exposure in NHANES 2005-2006. Clin Exp Allergy. 2015;45(10):1566-78.

26. Sopori M. Effects of cigarette smoke on the immune system. Nat Rev Immunol. 2002;2(5):372-7.

27. Abdualrasool M, Al-Shanfari S, Booalayan H, Boujarwa A, Al-Mukaimi A, Alkandery O, et al. Exposure to Environmental Tobacco Smoke and Prevalence of Atopic Dermatitis among Adolescents in Kuwait. Dermatology. 2018;234(5-6):186-91.

28. Huang SL, Lin KC, Pan WH. Dietary factors associated with physiciandiagnosed asthma and allergic rhinitis in teenagers: analyses of the first Nutrition and Health Survey in Taiwan. Clin Exp Allergy. 2001;31:259-64.

29. Kim SY, Sim S, Park B, Kim J-H, Choi HG. High-Fat and LowCarbohydrate Diets Are Associated with Allergic Rhinitis But Not Asthma or Atopic Dermatitis in Children. PLoS ONE. 2016;11(2):e0150202.

30. Oh S-T, Chung J, Kim MK, Kwon SO, Cho B-H. Antioxidant nutrient intakes and corresponding biomarkers associated with the risk of atopic dermatitis in young children. Eur J Clin Nutr. 2010;64(3):245‑52.

31. Mallol J, Aguirre V, Mallol-Simmonds M, Matamala- Bezmalinovic A, Calderón-Rodriguez L, Osses-Vergara F. Changes in the prevalence of asthma and related risk factors in adolescents: Three surveys between 1994 and 2015. Allergol Immunopathol (Madr). 2019;47(4):313-21.


Submitted date:
10/14/2020

Accepted date:
10/30/2020

6a184765a953954293068a76 aaai Articles
Links & Downloads

Arq Asma Alerg Imunol

Share this page
Page Sections